Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
Philips e-Alert MRI Monitoring System Vulnerable to Cyberattacks: Warning A hack of the e-Alert MRI monitoring system could silence crucial alarms, putting patients at risk of serious injury or death, the CISA warns. April 1, 2022 Russell Maas Add Your Comments As Philips continues to face a growing number of CPAP recall lawsuits being pursued by users who developed cancer and respiratory injuries from a defective sound abatement foam inside the sleep apnea machines, the beleaguered manufacturer has now acknowledged a serious cybersecurity vulnerability found in its e-Alert systems, which are used to monitor medical imagining devices. A Philips e-Alert cybersecurity warning was released by the U.S. Cybersecurity and Infrastructure Security Agency (CISA) on March 29, indicating certain versions of the device software contain vulnerabilities that could be exploited by hackers to silence critical alarms and expose users to life-threatening risks. Since 2014, the U.S. Department of Homeland Security (DHS) has been actively investigating at least two dozen cases of suspected cybersecurity flaws in medical devices and hospital equipment. DHS has warned that if preventative actions to strengthen the medical field’s cybersecurity issues are not taken, hackers could exploit these vulnerabilities and put patients at risk in a cyberattack. Stay Up-to-Date About Philips CPAP Recall Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Philips CPAP recall lawsuit updates or developments. "*" indicates required fields Email* Δ Learn More Stay Up-to-Date About Philips CPAP Recall Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Philips CPAP recall lawsuit updates or developments. "*" indicates required fields Email* Δ Learn More The Department of Homeland Security’s CISA issued the Medical Advisory warning for the Philips e-Alert devices, which are intelligent hardware and software-based tools that closely monitor healthcare facilities MRI system performances. The e-Alert systems use sensor technology to warn healthcare professionals and automatically shut down the systems when it identifies issues related to room temperature, helium levels, cyro compressor errors, magnet disruptions and other problems. CISA warns the cybersecurity vulnerability impacts versions 2.7 and earlier of Philips e-Alert, which the agency indicates lacks the requirement for authentication for accessing critical system functionality. If a hacker were to gain access to a healthcare facility’s network, the agency warns that it could allow a “low-skilled” unauthorized actor to remotely shutdown the system and prohibit critical preset alerts. CISA’s risk calculation gave the vulnerability a base score of 6.5 out of 10, which places the risk on the higher end of the medium-severity range. The advisory recommends healthcare facilities using the Philips e-Alert with versions 2.7 and earlier of the software minimize network exposure for all control systems, to ensure they are not accessible from the internet and to only allow authorized and trusted users remote access to the network using secure methods, such as VPNs. In conjunction with the CISA advisory, Philips released a Security Advisory on its webpage acknowledging the e-Alert vulnerability. Philips states that while the e-Alert systems are not a medical device, and do not pose a direct threat to patients, the company plans to release an update that will mitigate the vulnerability by the second quarter of 2022. Users with questions regarding the Philips e-Alert hardware solutions are being advised to contact their Customer Success Manager (CSM), local Philips service support team, or regional service support. Medical Device Cybersecurity Risks Cybersecurity threats in the medical field have been a growing concern over the last decade, as an increasing number of medical devices have been found to contain major vulnerabilities or run on unsupported operating systems, which could expose patients to serious risks. In 2019, the FDA issued a safety communication about vulnerabilities with Medtronic ICDs or cardiac resynchronization therapy defibrillators (CRT-Ds), after discovering the wireless telemetry system used to communicate and alter the implanted devices could be hacked due to a lack of security protocols. Later the same year in November, Medtronic issued a Medtronic MiniMed insulin pump recall after the manufacturer identified someone other than the patient or healthcare provider could remotely change insulin delivery settings and alter glucose level data, potentially leading to life threatening conditions such as the development of severe hypoglycemia or high blood sugar and diabetic ketoacidosis. Late last month, the multinational cybersecurity company, Palo Alto Networks, released the findings of their medical device cybersecurity report, warning that the majority of infusion pumps currently in use at healthcare facilities across the U.S. have security gaps that put them at increased risk of being hacked. The report revealed 75% of approximately 200,000 infusion pumps in-use contained major vulnerabilities to at least one of the 110 identified and known security threats which could allow hackers to compromise the infusion pump’s functionality. Tags: Cybersecurity, MRI, Philips More Philips CPAP Recall Lawsuit Stories Lawsuits Between Philips and SoClean Over CPAP Machine Problems To Be Trial Ready by July 2025 September 3, 2024 Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October July 11, 2024 Philips OmniLab Advanced+ Ventilator Recall Issued Over Loss of Therapy Risks July 1, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (Posted: 3 days ago) Parties involved in Covidien hernia mesh lawsuits indicate they are ready to meet with a mediator in a couple weeks to begin potential settlement negotiations. MORE ABOUT: HERNIA MESH LAWSUITCovidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)Discovery Deadlines in Covidien Hernia Mesh Lawsuits Extended by MDL Judge (12/12/2024)Court Appoints Bard Hernia Mesh Settlement Special Masters To Implement “Intensive” Process To Resolve Claims (11/22/2024) Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (Posted: 4 days ago) A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025) Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: 5 days ago) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)
Lawsuits Between Philips and SoClean Over CPAP Machine Problems To Be Trial Ready by July 2025 September 3, 2024
Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (Posted: 3 days ago) Parties involved in Covidien hernia mesh lawsuits indicate they are ready to meet with a mediator in a couple weeks to begin potential settlement negotiations. MORE ABOUT: HERNIA MESH LAWSUITCovidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)Discovery Deadlines in Covidien Hernia Mesh Lawsuits Extended by MDL Judge (12/12/2024)Court Appoints Bard Hernia Mesh Settlement Special Masters To Implement “Intensive” Process To Resolve Claims (11/22/2024)
Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (Posted: 4 days ago) A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025)
Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: 5 days ago) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)